Infectious disease solutions are critical for laboratories to protect community health. We proactively address emerging needs by delivering breakthrough innovations that empower laboratories to confidently identify pathogens impacting community health, maintain safe blood supplies, and connect those diagnosed with disease to the care they need.
For in vitro diagnostic use.
HIV's rapid evolution leads to genetic variations among different subtypes, differing by 25-35%1
Viral hepatitis was the second leading cause of death from communicable diseases in 20222
Despite nearing eradication, syphilis has reached crisis levels again, with 8M new infections globally in 20223
Since 1980, new pathogens causing disease in humans has emerged at a rate of over 3 per year4
Abbott’s Global Viral Surveillance Program has been at the forefront of monitoring HIV and Hepatitis since 1994.
But as viruses continue to mutate and move around the world faster than ever before, we have expanded our efforts to respond more quickly through the Abbott Pandemic Defense Coalition.
This first-of-its-kind global network, led by industry, is dedicated to end current epidemics and help prevent future pandemics, giving laboratorians, clinicians, and communities confidence for today and protection for tomorrow.
Guided by Abbott's history of innovation, our experts collaborate to overcome todays' infectious disease challenges and work to continually improve our diagnostic accuracy. Our comprehensive understanding of the rapidly changing infectious disease landscape is key to delivering clinical confidence and brings every person affected closer to the care they need.
Diagnosing HIV-positive individuals is critical to connect them to treatment and prevent the ongoing spread of infection so we can help end the HIV epidemic. Abbott's HIV assays enhance lab capabilities to confidently identify the virus, regardless of where it originated.
Our HAV, HBV and HCV assays are designed to overcome the viral hepatitis diagnostic challenges and help streamline the journey from diagnosis to care, supporting viral hepatitis elimination goals.
In the battle against the syphilis epidemic, timely and accurate testing plays a crucial role in early detection and treatment. Our automated solution provides accurate results, streamlines the diagnostic process, and enhances efficiency.
Confidently detect TORCH infections early in pregnancy to minimize mother-to-child transmission risks. Abbott's TORCH panel provides accurate results and streamlines lab workflows.
Coming off the COVID-19 pandemic, SARS-CoV-2 antibody testing can provide additional options to test patients and conduct ongoing research to understand the effects of the disease.
| Hepatitis |
| Anti-HBc |
| Anti-HBc IgM |
| Anti-HBc II |
| Anti-HBe |
| Anti-HBs |
| Anti-HCV |
| HAVAb IgG |
| HAVAb IgM |
| HBeAg |
| HBeAg Qualitative/Quantitative |
| HBsAg Quantitative |
| HBsAg Quantitative Confirmatory |
| HBsAg Next Confirmatory |
| HBsAg Next Qualitative |
| HBsAg Qualitative II |
| HBsAg Qualitative II Confirmatory |
| HCV Ag |
| Other Infectious Disease |
| Chagas |
| EBV EBNA-1-IgG |
| EBV VCA IgG |
| EBV VCA IgM |
| SARS-COV-2 IGG |
| SARS-COV-2 IgG II Quant |
| SARS-COV-2 IGM |
| Syphilis TP |
| RETROVIRUS |
| Anti-HTLV I/II |
| HIV Ag/Ab Combo |
| rHTLV-I/II |
| TORCH |
| CMV IgG |
| CMV IgG Avidity |
| CMV IgM |
| HSV-1 IgG |
| HSV-2 IgG |
| Rubella IgG |
| Rubella IgM |
| Toxo IgG |
| Toxo IgG Avidity |
| Toxo IgM |
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
